Cargando…

Inhibiting the MCM8‐9 complex selectively sensitizes cancer cells to cisplatin and olaparib

MCM8 and MCM9 are paralogues of the MCM2‐7 eukaryotic DNA replication helicase proteins and play a crucial role in a homologous recombination‐mediated repair process to resolve replication stress by fork stalling. Thus, deficiency of MCM8‐9 sensitizes cells to replication stress caused, for example,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morii, Issay, Iwabuchi, Yukiko, Mori, Sumiko, Suekuni, Masaki, Natsume, Toyoaki, Yoshida, Kazumasa, Sugimoto, Nozomi, Kanemaki, Masato T., Fujita, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398883/ https://www.ncbi.nlm.nih.gov/pubmed/30648820 http://dx.doi.org/10.1111/cas.13941

Ejemplares similares

Acute inactivation of the replicative helicase in human cells triggers MCM8–9-dependent DNA synthesis
por: Natsume, Toyoaki, et al.
Publicado: (2017)

The dimeric Mcm8–9 complex of Xenopus laevis likely has a conserved function for resistance to DNA damage
por: Kanemaki, Masato T.
Publicado: (2013)

Control of homologous recombination by the HROB–MCM8–MCM9 pathway
por: Hustedt, Nicole, et al.
Publicado: (2019)

The assembly of the MCM2–7 hetero-hexamer and its significance in DNA replication
por: Hatoyama, Yuki, et al.
Publicado: (2023)

Dynein–Dynactin–NuMA clusters generate cortical spindle-pulling forces as a multi-arm ensemble
por: Okumura, Masako, et al.
Publicado: (2018)

Cdt1-binding protein GRWD1 is a novel histone-binding protein that facilitates MCM loading through its influence on chromatin architecture
por: Sugimoto, Nozomi, et al.
Publicado: (2015)

Chromosome oscillation promotes Aurora A–dependent Hec1 phosphorylation and mitotic fidelity
por: Iemura, Kenji, et al.
Publicado: (2021)

Genome-wide analysis of the spatiotemporal regulation of firing and dormant replication origins in human cells
por: Sugimoto, Nozomi, et al.
Publicado: (2018)

MCMBP promotes the assembly of the MCM2–7 hetero-hexamer to ensure robust DNA replication in human cells
por: Saito, Yuichiro, et al.
Publicado: (2022)

TRF2-mediated ORC recruitment underlies telomere stability upon DNA replication stress
por: Higa, Mitsunori, et al.
Publicado: (2021)

Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity
por: Eaton, Joshua D., et al.
Publicado: (2018)

MCM10 compensates for Myc‐induced DNA replication stress in breast cancer stem‐like cells
por: Murayama, Takahiko, et al.
Publicado: (2021)

Molecular functions of MCM8 and MCM9 and their associated pathologies
por: Helderman, Noah Cornelis, et al.
Publicado: (2023)

Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer
por: Yarchoan, Mark, et al.
Publicado: (2017)

MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib
por: Whicker, Margaret E., et al.
Publicado: (2016)

Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician’s Perspective
por: Matsumoto, Takashi, et al.
Publicado: (2022)

Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin
por: Miyazawa, Yoshiyuki, et al.
Publicado: (2022)

Global landscape of replicative DNA polymerase usage in the human genome
por: Koyanagi, Eri, et al.
Publicado: (2022)

SLX4–XPF mediates DNA damage responses to replication stress induced by DNA–protein interactions
por: Ishimoto, Riko, et al.
Publicado: (2020)

The combination of olaparib and camptothecin for effective radiosensitization
por: Miura, Katsutoshi, et al.
Publicado: (2012)

Analysis of Adaptive Olaparib Resistance Effects on Cisplatin Sensitivity in Triple Negative Breast Cancer Cells
por: Gajan, Ambikai, et al.
Publicado: (2021)

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
por: Moutafi, Myrto, et al.
Publicado: (2023)

The RIF1-long splice variant promotes G1 phase 53BP1 nuclear bodies to protect against replication stress
por: Watts, Lotte P, et al.
Publicado: (2020)

Reproductive aging and MCM8/9
por: Yatsenko, Svetlana A., et al.
Publicado: (2015)

MCM-GINS and MCM-MCM interactions in vivo visualised by bimolecular fluorescence complementation in fission yeast
por: Akman, Gökhan, et al.
Publicado: (2009)

MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis()()
por: Issac, Marianne Samir Makboul, et al.
Publicado: (2019)

Synergistic effects of olaparib combined with ERCC1 on the sensitivity of cisplatin in non-small cell lung cancer
por: Xie, Kejie, et al.
Publicado: (2021)

Combination treatment with cisplatin, paclitaxel and olaparib has synergistic and dose reduction potential in ovarian cancer cells
por: Gao, Jianwen, et al.
Publicado: (2021)

Editorial Comment on “Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin”
por: Hatano, Koji
Publicado: (2022)

DNA Replication Origins and Fork Progression at Mammalian Telomeres
por: Higa, Mitsunori, et al.
Publicado: (2017)

Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property
por: Prasad, Chandra Bhushan, et al.
Publicado: (2017)

Different Residues on the Surface of the Methanothermobacter thermautotrophicus MCM Helicase Interact with Single- and Double-Stranded DNA
por: Sakakibara, Nozomi, et al.
Publicado: (2010)

O-GlcNAc transferase associates with the MCM2–7 complex and its silencing destabilizes MCM–MCM interactions
por: Leturcq, Maïté, et al.
Publicado: (2018)

Identification of candidate molecular targets of the novel antineoplastic antimitotic NP-10
por: Yokoyama, Takuya, et al.
Publicado: (2019)

Olaparib in the management of ovarian cancer
por: Bixel, Kristin, et al.
Publicado: (2015)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

Olaparib: Transcending mutational barriers
por: Chandna, Abhishek
Publicado: (2019)

Olaparib and somatic BRCA mutations
por: George, Angela, et al.
Publicado: (2017)

Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin
por: Vareki, Saman Maleki, et al.
Publicado: (2014)

Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report
por: Lai, Yi-Hsuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_afqk4814oc78hf8kiilrgednac